Rivaroxaban

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Direct Oral AntiCoagulants and Ticagrelor Study II

Not yet recruiting
  • Novel Oral Anticoagulants
  • +11 more
  • Detection of genotype and RNA profile in platelet and white blood cell
  • +2 more
  • Hefei, Anhui, China
  • +5 more
Mar 1, 2023

Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,

Not yet recruiting
  • Kawasaki Disease
  • +4 more
  • Rivaroxaban Oral Tablet or Suspension [Xarelto]
  • +2 more
  • (no location specified)
Dec 6, 2022

Cancer, Rivaroxaban, Venous Thromboembolism Trial in Santo André (Rivaroxaban, Enoxaparin)

Recruiting
  • Cancer
  • +3 more
  • Santo André, São Paulo, Brazil
    Science Valley Research Institute
Aug 3, 2021

Rivaroxaban Trial (clopidogrel combined with rivaroxaban arm)

Not yet recruiting
  • Rivaroxaban
  • clopidogrel combined with rivaroxaban arm
  • (no location specified)
Mar 16, 2021

Pharmacodynamics of Direct Oral Anticoagulants

Unknown status
  • Novel Oral Anticoagulants
  • +8 more
  • detection of genotype
  • Hefei, Anhui, China
  • +16 more
Dec 19, 2020

Rivaroxaban in Elderly NVAF or Without Renal Impairment

Unknown status
  • Atrial Fibrillation
  • +3 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Oct 19, 2020

Rivaroxaban, Thromboprophylaxis, Cancer Trial (Rivaroxaban)

Unknown status
  • Rivaroxaban
  • +2 more
  • (no location specified)
Mar 12, 2020

Atrial Fibrillation, Left Atrial Appendage Thrombosis, Rivaroxaban Trial (Rivaroxaban, Warfarin)

Unknown status
  • Atrial Fibrillation
  • +2 more
  • (no location specified)
Mar 18, 2019

Rivaroxaban, Cancer-associated Thrombosis, Recurrence Trial in Seongnam (Rivaroxaban)

Completed
  • Rivaroxaban
  • +3 more
  • Seongnam, Korea, Republic of
    Seoul National University Bundang Hospital
Jan 6, 2017